Showing results (91-100 of 156) with videos related to
Sort By:
Pageof 16
Journal of Experimental & Clinical Cancer Research : CR|April 28, 2019
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLCVincenza Ciaramella, Ferdinando Carlo Sasso, Raimondo Di Liello, et al.Journal of Experimental & Clinical Cancer Research : CR|June 15, 2019
Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid culturesCarminia Maria Della Corte, Giusi Barra, Vincenza Ciaramella, et al.Cancers|April 13, 2023
PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant PhenotypeStefano Lucà, Renato Franco, Antonella Napolitano, et al.Oncotargets and Therapy|February 27, 2020
Nivolumab in Heavily Pretreated Metastatic Gastric Cancer Patients: Real-Life Data from a Western PopulationAngelica Petrillo, Giuseppe Tirino, Federica Zito Marino, et al.Journal of Medicinal Chemistry|August 9, 2017
Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung CancerFloriana Morgillo, Giorgio Amendola, Carminia Maria Della Corte, et al.The Journal of Liquid Biopsy|March 3, 2025
New perspectives on inoperable early-stage lung cancer management: Clinicians, physicists, and biologists unveil strategies and insightsMauro Buono, Gianluca Russo, Valerio Nardone, et al.ESMO Open|August 2, 2017
Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancerFloriana Morgillo, Morena Fasano, Carminia Maria Della Corte, et al.Oncotarget|December 18, 2015
Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cellsCarminia Maria Della Corte, Vincenza Ciaramella, Concetta Di Mauro, et al.The Oncologist|May 23, 2022
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the COVID-19 PandemicStefania Napolitano, Vincenza Caputo, Anna Ventriglia, et al.Oncotarget|October 6, 2017
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancerValentina Belli, Vincenzo Sforza, Claudia Cardone, et al.Pageof 16